Prostate cancer is is the most common solid neoplasm and it is now recognized as one of the most important medical problems facing the male population. Due to its long latency and its identifiable preneoplastic lesions, prostate cancer is an ideal target tumor for chemoprevention. Different compounds are available and certainly polyphenols represent those with efficacy against prostate cancer. This review take a look at activity and properties of major polyphenolic substances, such as epigallocatechin-3-gallate, curcumin, resveratrol and the flavonoids quercetin and genistein. Although the current studies are limited, mechanisms of action of polyphenols added with the lack of side effects show a a start for future strategies in prostate chemoprevention.
Polyphenols: key issues involved in chemoprevention of prostate cancer / Madonia, Massimo; Cimino, Sebastiano; Sortino, Giuseppe; Castelli, Tommaso; Sansalone, Salvatore; Morgia, Giuseppe; Favilla, Vincenzo; Russo, Giorgio Ivan. - 2012:(2012). [10.1155/2012/632959]
Polyphenols: key issues involved in chemoprevention of prostate cancer
Madonia, Massimo;Morgia, Giuseppe;
2012-01-01
Abstract
Prostate cancer is is the most common solid neoplasm and it is now recognized as one of the most important medical problems facing the male population. Due to its long latency and its identifiable preneoplastic lesions, prostate cancer is an ideal target tumor for chemoprevention. Different compounds are available and certainly polyphenols represent those with efficacy against prostate cancer. This review take a look at activity and properties of major polyphenolic substances, such as epigallocatechin-3-gallate, curcumin, resveratrol and the flavonoids quercetin and genistein. Although the current studies are limited, mechanisms of action of polyphenols added with the lack of side effects show a a start for future strategies in prostate chemoprevention.File | Dimensione | Formato | |
---|---|---|---|
Cimino_S_Polyphenols_key_issues_involved.pdf
accesso aperto
Tipologia:
Versione editoriale (versione finale pubblicata)
Licenza:
Creative commons
Dimensione
741.06 kB
Formato
Adobe PDF
|
741.06 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.